Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up - Yahoo Finance

Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up  Yahoo Finance

Sanofi (SNY) beats estimates for second-quarter earnings. Key immunology drug Dupixent drives sales. The company ups its earnings growth expectations for ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases